Contribute Try STAT+ Today

Rise and shine, everyone, another busy day is on the way. We can tell because our short person — who now drives but remains shorter than us — has left for another day of work called pamper the camper. And our official mascot is lounging about before his usual morning stroll. As for us, we are firing up the coffee kettle and making cups of stimulation. Our choice today is butter pecan. Feel free to join us. Your neurons will thank you. Meanwhile, here are some items of interest to help you on your journey, which we hope will be productive. Good luck…

Big drug makers and their lobbyists have a message for Congress: Don’t raise taxes on the industry that brought you fast-tracked Covid-19 vaccines, The Wall Street Journal says. Pharma executives, lobbyists, and consultants are mobilizing to fight a sweeping agreement by many of the world’s biggest economies to harmonize corporate taxation around the globe. Earlier this month, 130 countries agreed to broad outlines of a deal to establish a minimum corporate tax of 15%, reducing opportunities for international tax avoidance.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment